In situ tissue regeneration: Chemoattractants for endogenous stem cell recruitment

Tissue Engineering - Part B: Reviews

Volumn 20, Issue 1, 2014, Pages 28-39

  Vanden Berg Foels, Wendy S ^a,b  

^a AMRL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETIC APPROACHES; CELL CULTURE METHODS; CHEMOATTRACTANTS; DISEASED TISSUES; ENDOGENOUS STEM CELLS; MESENCHYMAL STEM CELL; PROOF OF CONCEPT; SIGNALING MOLECULES;

BIOASSAY; BIOMATERIALS; BIOMIMETICS; CELL CULTURE; CELL SIGNALING; REPAIR; STEM CELLS; TISSUE;

TISSUE REGENERATION;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CHEMOATTRACTANT; CHEMOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FRACTALKINE; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 8; LYSOPHOSPHOLIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UNINDEXED DRUG; VASCULOTROPIN A;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CULTURE TECHNIQUE; ENVIRONMENT; EX VIVO STUDY; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; MORPHOGENESIS; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; CHEMOTACTIC FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; REGENERATION; STEM CELLS; TISSUE ENGINEERING; WOUND HEALING;

EID: 84892955589     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2013.0100     Document Type: Article

References (176)

1. Brockes, J.P., and Kumar, A. Appendage regeneration in adult vertebrates and implications for regenerative medicine. Science 310, 1919, 2005.
2. Atala, A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 1, 83, 2007.
3. Korbling, M., and Estrov, Z. Adult stem cells for tissue repair-a new therapeutic concept? N Engl J Med 349, 570, 2003.
4. Alonso, L., and Fuchs, E. Stem cells of the skin epithelium. Proc Natl Acad Sci USA 100 Suppl 1, 11830, 2003.
5. Harada, S., and Rodan, G.A. Control of osteoblast function and regulation of bone mass. Nature 423, 349, 2003.
6. Olsen, B.R., Reginato, A.M., and Wang, W. Bone development. Annu Rev Cell Dev Biol 16, 191, 2000.
7. Lenas, P., Moos, M., and Luyten, F.P. Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from threedimensional cell growth to biomimetics of in vivo development. Tissue Eng Part B Rev 15, 381, 2009.
8. Friedenstein, A.J., Petrakova, K.V., Kurolesova, A.I., and Frolova, G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230, 1968.
9. Kuhn, N.Z., and Tuan, R.S. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 222, 268, 2010.
10. Liu, Z.J., Zhuge, Y., and Velazquez, O.C. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106, 984, 2009.
11. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
12. da Silva Meirelles, L., Caplan, A.I., and Nardi, N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26, 2287, 2008.
13. Chen, C.W., Montelatici, E., Crisan, M., Corselli, M., Huard, J., Lazzari, L., et al. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 20, 429, 2009.
14. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
15. Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., and Shimizu, H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180, 2581, 2008.
16. Dezawa, M. Systematic neuronal and muscle induction systems in bone marrow stromal cells: the potential for tissue reconstruction in neurodegenerative and muscle degenerative diseases. Med Mol Morphol 41, 14, 2008.
17. Sato, Y., Araki, H., Kato, J., Nakamura, K., Kawano, Y., Kobune, M., et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106, 756, 2005.
18. da Silva Meirelles, L., Fontes, A.M., Covas, D.T., and Caplan, A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20, 419, 2009.
19. Horwitz, E.M., and Dominici, M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 10, 771, 2008.
20. Fodor, W.L. Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate. Reprod Biol Endocrinol 1, 102, 2003.
21. Parekkadan, B., and Milwid, J.M. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12, 87, 2010.
22. Holzwarth, J.M., and Ma, P.X. Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 32, 9622, 2011.
23. Song, J.J., and Ott, H.C. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 17, 424, 2011.
24. Vinatier, C., Bouffi, C., Merceron, C., Gordeladze, J., Brondello, J.M., Jorgensen, C., et al. Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther 4, 318, 2009.
25. Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A.M., and Silberstein, L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24, 1030, 2006.
26. De Becker, A., Van Hummelen, P., Bakkus, M., Vande Broek, I., De Wever, J., De Waele, M., et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92, 440, 2007.
27. Karp, J.M., and Leng Teo, G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4, 206, 2009.
28. Newman, R.E., Yoo, D., LeRoux, M.A., and Danilkovitch-Miagkova, A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8, 110, 2009.
29. Evans, C.H., Palmer, G.D., Pascher, A., Porter, R., Kwong, F.N., Gouze, E., et al. Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 13, 1987, 2007.
30. Anitua, E., Sanchez, M., and Orive, G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 62, 741, 2010.
31. Chen, F.M., Wu, L.A., Zhang, M., Zhang, R., and Sun, H.H. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives. Biomaterials 32, 3189, 2011.
32. Richter, W. Mesenchymal stem cells and cartilage in situ regeneration. J Intern Med 266, 390, 2009.
33. Schagemann, J.C., Erggelet, C., Chung, H.W., Lahm, A., Kurz, H., and Mrosek, E.H. Cell-laden and cell-free biopolymer hydrogel for the treatment of osteochondral defects in a sheep model. Tissue Eng Part A 15, 75, 2009.
34. Erggelet, C., Neumann, K., Endres, M., Haberstroh, K., Sittinger, M., and Kaps, C. Regeneration of ovine articular cartilage defects by cell-free polymer-based implants. Biomaterials 28, 5570, 2007.
35. Tamai, N., Myoui, A., Hirao, M., Kaito, T., Ochi, T., Tanaka, J., et al. A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2). Osteoarthritis Cartilage 13, 405, 2005.
36. Emans, P.J., van Rhijn, L.W., Welting, T.J., Cremers, A., Wijnands, N., Spaapen, F., et al. Autologous engineering of cartilage. Proc Natl Acad Sci USA 107, 3418, 2010.
37. Lee, C.H., Cook, J.L., Mendelson, A., Moioli, E.K., Yao, H., and Mao, J.J. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 376, 440, 2010.
38. Suzuki, T., Lee, C.H., Chen, M., Zhao, W., Fu, S.Y., Qi, J.J., et al. Induced migration of dental pulp stem cells for in vivo pulp regeneration. J Dent Res 90, 1013, 2011.
39. Laird, D.J., von Andrian, U.H., and Wagers, A.J. Stem cell trafficking in tissue development, growth, and disease. Cell 132, 612, 2008.
40. Ingber, D.E., Mow, V.C., Butler, D., Niklason, L., Huard, J., Mao, J., et al. Tissue engineering and developmental biology: going biomimetic. Tissue Eng 12, 3265, 2006.
41. Li, L., and Jiang, J. Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms. Front Med 5, 33, 2011.
42. Crouzier, T., Fourel, L., Boudou, T., Albiges-Rizo, C., and Picart, C. Presentation of BMP-2 from a soft biopolymeric film unveils its activity on cell adhesion and migration. Adv Mater 23, H111, 2011.
43. Cohn, M.J., Izpisua-Belmonte, J.C., Abud, H., Heath, J.K., and Tickle, C. Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 80, 739, 1995.
44. Lorenz, H.P., and Longaker, M.T. Wounds Biology, Pathology, and Management. Essential Practice of Surgery. New York: Sprinter, 2003.
45. Alvarez, R.H., Kantarjian, H.M., and Cortes, J.E. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81, 1241, 2006.
46. Fang, L., Yan, Y., Komuves, L.G., Yonkovich, S., Sullivan, C.M., Stringer, B., et al. PDGF C is a selective alpha plateletderived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler Thromb Vasc Biol 24, 787, 2004.
47. Fiedler, J., Etzel, N., and Brenner, R.E. To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93, 990, 2004.
48. Mishima, Y., and Lotz, M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 26, 1407, 2008.
49. Ponte, A.L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737, 2007.
50. Somers, P., Cornelissen, R., Thierens, H., and Van Nooten, G. An optimized growth factor cocktail for ovine mesenchymal stem cells. Growth Factors 30, 37, 2012.
51. Ruster, B., Grace, B., Seitz, O., Seifried, E., and Henschler, R. Induction and detection of human mesenchymal stem cell migration in the 48-well reusable transwell assay. Stem Cells Dev 14, 231, 2005.
52. Nedeau, A.E., Bauer, R.J., Gallagher, K., Chen, H., Liu, Z.J., and Velazquez, O.C. A CXCL5-and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res 314, 2176, 2008.
53. Lee, J.M., Kim, B.S., Lee, H., and Im, G.I. In vivo tracking of mesechymal stem cells using fluorescent nanoparticles in an osteochondral repair model. Mol Ther 20, 1434, 2012.
54. Baker, J., Liu, J.P., Robertson, E.J., and Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73, 1993.
55. Linkhart, T.A., Mohan, S., and Baylink, D.J. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 19, 1S, 1996.
56. Adams, T.E., Epa, V.C., Garrett, T.P., and Ward, C.W. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57, 1050, 2000.
57. Fiedler, J., Brill, C., Blum, W.F., and Brenner, R.E. IGF-I and IGF-II stimulate directed cell migration of bone-marrowderived human mesenchymal progenitor cells. Biochem Biophys Res Commun 345, 1177, 2006.
58. Ozaki, Y., Nishimura, M., Sekiya, K., Suehiro, F., Kanawa, M., Nikawa, H., et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16, 119, 2007.
59. Haider, H., Jiang, S., Idris, N.M., and Ashraf, M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103, 1300, 2008.
60. Thomas, T., Gori, F., Spelsberg, T.C., Khosla, S., Riggs, B.L., and Conover, C.A. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140, 5036, 1999.
61. Sieber, C., Kopf, J., Hiepen, C., and Knaus, P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 20, 343, 2009.
62. Chen, D., Zhao, M., and Mundy, G.R. Bone morphogenetic proteins. Growth Factors 22, 233, 2004.
63. Li, X., and Cao, X. BMP signaling and skeletogenesis. Ann N Y Acad Sci 1068, 26, 2006.
64. Massague, J., Blain, S.W., and Lo, R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103, 295, 2000.
65. Cho, T.J., Gerstenfeld, L.C., and Einhorn, T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17, 513, 2002.
66. Chen, G., Deng, C., and Li, Y.P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8, 272, 2012.
67. Huang, F., and Chen, Y.G. Regulation of TGF-beta receptor activity. Cell Biosci 2, 9, 2012.
68. Bostrom, M.P., Lane, J.M., Berberian, W.S., Missri, A.A., Tomin, E., Weiland, A., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13, 357, 1995.
69. Yu, Y.Y., Lieu, S., Lu, C., Miclau, T., Marcucio, R.S., and Colnot, C. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 46, 841, 2010.
70. Fiedler, J., Roderer, G., Gunther, K.P., and Brenner, R.E. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87, 305, 2002.
71. Boon, M.R., van der Horst, G., van der Pluijm, G., Tamsma, J.T., Smit, J.W., and Rensen, P.C. Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency. Cytokine Growth Factor Rev 22, 221, 2011.
72. Gautschi, O.P., Frey, S.P., and Zellweger, R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 77, 626, 2007.
73. Baek, S.J., Kang, S.K., and Ra, J.C. In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med 43, 596, 2011.
74. Mendelson, A., Frank, E., Allred, C., Jones, E., Chen, M., Zhao, W., et al. Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. FASEB J 25, 3496, 2011.
75. Wells, A. EGF receptor. Int J Biochem Cell Biol 31, 637, 1999.
76. Tamama, K., Fan, V.H., Griffith, L.G., Blair, H.C., and Wells, A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24, 686, 2006.
77. Baer, P.C., Schubert, R., Bereiter-Hahn, J., Plosser, M., and Geiger, H. Expression of a functional epidermal growth factor receptor on human adipose-derived mesenchymal stem cells and its signaling mechanism. Eur J Cell Biol 88, 273, 2009.
78. Lauffenburger, D.A., and Horwitz, A.F. Cell migration: a physically integrated molecular process. Cell 84, 359, 1996.
79. Polk, W.H., Jr., Dempsey, P.J., Russell, W.E., Brown, P.I., Beauchamp, R.D., Barnard, J.A., et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 102, 1467, 1992.
80. Vassar, R., and Fuchs, E. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev 5, 714, 1991.
81. Wang, Y., Crisostomo, P.R., Wang, M., Markel, T.A., Novotny, N.M., and Meldrum, D.R. TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK-and PI3-K-but not JNK-or ERK-dependent mechanisms. Am J Physiol Regul Integr Comp Physiol 295, R1115, 2008.
82. Ornitz, D.M., and Itoh, N. Fibroblast growth factors. Genome Biol 2, REVIEWS3005.1, 2001.
83. Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D.B. Biological roles of fibroblast growth factor-2. Endocr Rev 18, 26, 1997.
84. Ortega, S., Ittmann, M., Tsang, S.H., Ehrlich, M., and Basilico, C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 95, 5672, 1998.
85. Itoh, N. The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol Pharm Bull 30, 1819, 2007.
86. Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A., Coulier, F., et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271, 15292, 1996.
87. Annabi, B., Thibeault, S., Lee, Y.T., Bousquet-Gagnon, N., Eliopoulos, N., Barrette, S., et al. Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. Exp Hematol 31, 640, 2003.
88. Schmidt, A., Ladage, D., Schinkothe, T., Klausmann, U., Ulrichs, C., Klinz, F.J., et al. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24, 1750, 2006.
89. Uchida, K., Urabe, K., Naruse, K., Ujihira, M., Mabuchi, K., and Itoman, M. Comparison of the cytokine-induced migratory response between primary and subcultured populations of rat mesenchymal bone marrow cells. J Orthop Sci 12, 484, 2007.
90. Boros, P., and Miller, C.M. Hepatocyte growth factor: a multifunctional cytokine. Lancet 345, 293, 1995.
91. Matsumoto, K., and Nakamura, T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239, 639, 1997.
92. Bevan, D., Gherardi, E., Fan, T.P., Edwards, D., and Warn, R. Diverse and potent activities of HGF/SF in skin wound repair. J Pathol 203, 831, 2004.
93. Neuss, S., Becher, E., Woltje, M., Tietze, L., and Jahnen-Dechent, W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22, 405, 2004.
94. Son, B.R., Marquez-Curtis, L.A., Kucia, M., Wysoczynski, M., Turner, A.R., Ratajczak, J., et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24, 1254, 2006.
95. Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnocchi, V., et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24, 23, 2006.
96. Cross, M.J., Dixelius, J., Matsumoto, T., and Claesson-Welsh, L. VEGF-receptor signal transduction. Trends Biochem Sci 28, 488, 2003.
97. Zachary, I., and Gliki, G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49, 568, 2001.
98. Ball, S.G., Shuttleworth, C.A., and Kielty, C.M. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol 177, 489, 2007.
99. Okuyama, H., Krishnamachary, B., Zhou, Y.F., Nagasawa, H., Bosch-Marce, M., and Semenza, G.L. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 281, 15554, 2006.
100. Annabi, B., Lee, Y.T., Turcotte, S., Naud, E., Desrosiers, R.R., Champagne, M., et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21, 337, 2003.
101. Kim, J.Y., Xin, X., Moioli, E.K., Chung, J., Lee, C.H., Chen, M., et al. Regeneration of dental-pulp-like tissue by chemotaxis-induced cell homing. Tissue Eng Part A 16, 3023, 2010.
102. Baggiolini, M. Chemokines and leukocyte traffic. Nature 392, 565, 1998.
103. Clark-Lewis, I., Kim, K.S., Rajarathnam, K., Gong, J.H., Dewald, B., Moser, B., et al. Structure-activity relationships of chemokines. J Leukoc Biol 57, 703, 1995.
104. McGrath, K.E., Koniski, A.D., Maltby, K.M., McGann, J.K., and Palis, J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 213, 442, 1999.
105. Rezzoug, F., Seelan, R.S., Bhattacherjee, V., Greene, R.M., and Pisano, M.M. Chemokine-mediated migration of mesencephalic neural crest cells. Cytokine 56, 760, 2011.
106. Gillitzer, R., and Goebeler, M. Chemokines in cutaneous wound healing. J Leukoc Biol 69, 513, 2001.
107. Kitaori, T., Ito, H., Schwarz, E.M., Tsutsumi, R., Yoshitomi, H., Oishi, S., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60, 813, 2009.
108. Togel, F., Isaac, J., Hu, Z., Weiss, K., and Westenfelder, C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67, 1772, 2005.
109. Shen, L.H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 27, 6, 2007.
110. Abbott, J.D., Huang, Y., Liu, D., Hickey, R., Krause, D.S., and Giordano, F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110, 3300, 2004.
111. Wang, Y., Johnsen, H.E., Mortensen, S., Bindslev, L., Ripa, R.S., Haack-Sorensen, M., et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92, 768, 2006.
112. De La Luz Sierra, M., Yang, F., Narazaki, M., Salvucci, O., Davis, D., Yarchoan, R., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103, 2452, 2004.
113. Sordi, V., Malosio, M.L., Marchesi, F., Mercalli, A., Melzi, R., Giordano, T., et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106, 419, 2005.
114. Ji, J.F., He, B.P., Dheen, S.T., and Tay, S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22, 415, 2004.
115. Thevenot, P.T., Nair, A.M., Shen, J., Lotfi, P., Ko, C.Y., and Tang, L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 31, 3997, 2010.
116. Schantz, J.T., Chim, H., and Whiteman, M. Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng 13, 2615, 2007.
117. Wang, L., Li, Y., Chen, J., Gautam, S.C., Zhang, Z., Lu, M., et al. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 30, 831, 2002.
118. Wang, L., Li, Y., Chen, X., Chen, J., Gautam, S.C., Xu, Y., et al. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7, 113, 2002.
119. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005, 2001.
120. Belema-Bedada, F., Uchida, S., Martire, A., Kostin, S., and Braun, T. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2, 566, 2008.
121. Kameyoshi, Y., Dorschner, A., Mallet, A.I., Christophers, E., and Schroder, J.M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176, 587, 1992.
122. Schall, T.J., Bacon, K., Toy, K.J., and Goeddel, D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347, 669, 1990.
123. Godiska, R., Chantry, D., Raport, C.J., Sozzani, S., Allavena, P., Leviten, D., et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185, 1595, 1997.
124. Ishida, Y., Kimura, A., Kuninaka, Y., Inui, M., Matsushima, K., Mukaida, N., et al. Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. J Clin Invest 122, 711, 2012.
125. Stich, S., Loch, A., Leinhase, I., Neumann, K., Kaps, C., Sittinger, M., et al. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur J Cell Biol 87, 365, 2008.
126. D'Haese, J.G., Demir, I.E., Friess, H., and Ceyhan, G.O. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets 14, 207, 2010.
127. Umehara, H., Tanaka, M., Sawaki, T., Jin, Z.X., Huang, C.R., Dong, L., et al. Fractalkine in rheumatoid arthritis and allied conditions. Mod Rheumatol 16, 124, 2006.
128. Umehara, H., Bloom, E.T., Okazaki, T., Nagano, Y., Yoshie, O., and Imai, T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24, 34, 2004.
129. Ishida, Y., Gao, J.L., and Murphy, P.M. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 180, 569, 2008.
130. Croitoru-Lamoury, J., Lamoury, F.M., Zaunders, J.J., Veas, L.A., and Brew, B.J. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J Interferon Cytokine Res 27, 53, 2007.
131. Nagira, M., Imai, T., Hieshima, K., Kusuda, J., Ridanpaa, M., Takagi, S., et al. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem 272, 19518, 1997.
132. Saeki, H., and Tamaki, K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 43, 75, 2006.
133. Serra, H.M., Baena-Cagnani, C.E., and Eberhard, Y. Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine? Allergy 59, 1219, 2004.
134. Ishii, I., Fukushima, N., Ye, X., and Chun, J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 73, 321, 2004.
135. Pebay, A., Bonder, C.S., and Pitson, S.M. Stem cell regulation by lysophospholipids. Prostaglandins Other Lipid Mediat 84, 83, 2007.
136. Watterson, K.R., Lanning, D.A., Diegelmann, R.F., and Spiegel, S. Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen 15, 607, 2007.
137. Chun, J., Hla, T., Lynch, K.R., Spiegel, S., and Moolenaar, W.H. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 62, 579, 2010.
138. Song, H.Y., Lee, M.J., Kim, M.Y., Kim, K.H., Lee, I.H., Shin, S.H., et al. Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis. Biochim Biophys Acta 1801, 23, 2010.
139. Lee, M.J., Jeon, E.S., Lee, J.S., Cho, M., Suh, D.S., Chang, C.L., et al. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells. J Cell Biochem 104, 499, 2008.
140. Demoyer, J.S., Skalak, T.C., and Durieux, M.E. Lysophosphatidic acid enhances healing of acute cutaneous wounds in the mouse. Wound Repair Regen 8, 530, 2000.
141. Balazs, L., Okolicany, J., Ferrebee, M., Tolley, B., and Tigyi, G. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol 280, R466, 2001.
142. English, D., Welch, Z., Kovala, A.T., Harvey, K., Volpert, O.V., Brindley, D.N., et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 14, 2255, 2000.
143. Chae, S.S., Paik, J.H., Furneaux, H., and Hla, T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 114, 1082, 2004.
144. Du, W., Takuwa, N., Yoshioka, K., Okamoto, Y., Gonda, K., Sugihara, K., et al. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Res 70, 772, 2010.
145. Meriane, M., Duhamel, S., Lejeune, L., Galipeau, J., and Annabi, B. Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphateinduced mobilization of marrow-derived stromal cells. Stem Cells 24, 2557, 2006.
146. Li, C., Kong, Y., Wang, H., Wang, S., Yu, H., Liu, X., et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50, 1174, 2009.
147. Andersson, U., Erlandsson-Harris, H., Yang, H., and Tracey, K.J. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72, 1084, 2002.
148. Ulloa, L., and Messmer, D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 17, 189, 2006.
149. Meng, E., Guo, Z., Wang, H., Jin, J., Wang, J., Wu, C., et al. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev 17, 805, 2008.
150. Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109, 1422, 2007.
151. Palumbo, R., and Bianchi, M.E. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 68, 1165, 2004.
152. Idriss, H.T., and Naismith, J.H. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50, 184, 2000.
153. Fu, X., Han, B., Cai, S., Lei, Y., Sun, T., and Sheng, Z. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen 17, 185, 2009.
154. Zhang, A., Wang, Y., Ye, Z., Xie, H., Zhou, L., and Zheng, S. Mechanism of TNF-alpha-induced migration and hepatocyte growth factor production in human mesenchymal stem cells. J Cell Biochem 111, 469, 2010.
155. Wang, M., Crisostomo, P.R., Herring, C., Meldrum, K.K., and Meldrum, D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 291, R880, 2006.
156. Xiao, Q., Wang, S.K., Tian, H., Xin, L., Zou, Z.G., Hu, Y.L., et al. TNF-alpha increases bone marrow mesenchymal stem cell migration to ischemic tissues. Cell Biochem Biophys 62, 409, 2012.
157. Waterman, R.S., Tomchuck, S.L.,Henkle, S.L., and Betancourt, A.M. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 5, e10088, 2010.
158. West, A.P., Koblansky, A.A., and Ghosh, S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22, 409, 2006.
159. Tomchuck, S.L., Zwezdaryk, K.J., Coffelt, S.B., Waterman, R.S., Danka, E.S., and Scandurro, A.B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26, 99, 2008.
160. Augello, A., Kurth, T.B., and De Bari, C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20, 121, 2010.
161. De Bari, C., Dell'Accio, F., Karystinou, A., Guillot, P.V., Fisk, N.M., Jones, E.A., et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58, 240, 2008.
162. Sung, J.H., Yang, H.M., Park, J.B., Choi, G.S., Joh, J.W., Kwon, C.H., et al. Isolation and characterization of mouse mesenchymal stem cells. Transplant Proc 40, 2649, 2008.
163. Baksh, D., Yao, R., and Tuan, R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25, 1384, 2007.
164. Mitsiadis, T.A., Barrandon, O., Rochat, A., Barrandon, Y., and De Bari, C. Stem cell niches in mammals. Exp Cell Res 313, 3377, 2007.
165. Lutolf, M.P., and Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23, 47, 2005.
166. Lavery, K., Swain, P., Falb, D., and Alaoui-Ismaili, M.H. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 283, 20948, 2008.
167. Satomura, K., Derubeis, A.R., Fedarko, N.S., Ibaraki-O'Connor, K., Kuznetsov, S.A., Rowe, D.W., et al. Receptor tyrosine kinase expression in human bone marrow stromal cells. J Cell Physiol 177, 426, 1998.
168. Walsh, S., Jefferiss, C., Stewart, K., Jordan, G.R., Screen, J., and Beresford, J.N. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 27, 185, 2000.
169. Gronthos, S., and Simmons, P.J. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85, 929, 1995.
170. Sorrentino, A., Ferracin, M., Castelli, G., Biffoni, M., Tomaselli, G., Baiocchi, M., et al. Isolation and characterization of CD146 + multipotent mesenchymal stromal cells. Exp Hematol 36, 1035, 2008.
171. Fiedler, J., Leucht, F., Waltenberger, J., Dehio, C., and Brenner, R.E.
172. Von Luttichau, I., Notohamiprodjo, M., Wechselberger, A., Peters, C., Henger, A., Seliger, C., et al. Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev 14, 329, 2005.
173. Brooke, G., Tong, H., Levesque, J.P., and Atkinson, K. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 17, 929, 2008.
174. Ringe, J., Strassburg, S., Neumann, K., Endres, M., Notter, M., Burmester, G.R., et al. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem 101, 135, 2007.
175. Ruster, B., Gottig, S., Ludwig, R.J., Bistrian, R., Muller, S., Seifried, E., et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108, 3938, 2006.
176. Park, J.S., Svetkauskaite, D., He, Q., Kim, J.Y., Strassheim, D., Ishizaka, A., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279, 7370, 2004.